- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Pharmaceutical Technology-05-02-2012
Pharmaceutical Technology
Optimizing Tableting Processes with Quality by Design
May 02, 2012
Special Reports
36
5
A technical forum featuring Tim Freeman of Freeman Technology and Carl Levoguer of Malvern Instruments.
FDA Explores Options to Expand Access to Non-Rx Drugs
May 02, 2012
Regulatory Watch
36
5
Manufacturers seek clear path to develop safe-use approaches for more risky OTC therapies.
All Eyes Alert
May 02, 2012
Agent-in Place
36
5
It's better to catch costly mistakes in the laboratory before they reach the accounting department.
Facilitating Efficient Equipment Cleaning
May 02, 2012
Troubleshooting
36
5
Equipment design and cleaning procedures both play a role in thorough sterilization and cleaning.
Formulation Development Forum: Targeted Polymeric Nanoparticles
May 02, 2012
Pharma Ingredients
36
5
Targeted polymeric nanoparticles are an important vehicle for controlling and targeting dosing of chemotherapeutic agents.
Meeting Manufacturing Challenges Tied to Extended-Release Injectables
May 02, 2012
Special Reports
36
5
Industry experts working with extended-release injectables discuss challenges and solutions to formulating and manufacturing these complex products.
FDA Perspectives: Scientific Considerations of Forced Degradation Studies in ANDA Submissions
May 02, 2012
Special Features
36
5
The author outlines the scientific aspects of forced degradation studies that should be considered in relation to ANDA submissions.
Some Supply Chain Lessons Can Go a Long Way towards Success
May 02, 2012
From The Editor
36
5
Apple's experience with manufacturing facilities in China present opportunity for future best practice.
Channeling Steve Jobs
May 02, 2012
Outsourcing Outlook
36
5
Service providers must focus on delivering a superior customer experience.
The Growing Orphan-Drug Paradigm
May 02, 2012
Viewpoint
36
5
How niche strategies can offer mainstream potential for biopharmaceutical companies.
Optimizing Drug Delivery for Modern Biologics
May 02, 2012
Special Features
36
5
The author discusses potential opportunities to improve the patient experience through formulation and delivery device technologies.
Report from Poland
May 02, 2012
In the Field
36
5
Poland's government aims to make the Eastern European country a biotech powerhouse.
Seeking Chemocatalytic and Biocatalytic Solutions
May 02, 2012
Pharma Ingredients
36
5
Advances in palladium-catalyzed hydrogenation, visible-light photocatalysis, and chemocatalyisis for heterocycles are some recent developments.
Tackling Global Health Concerns
May 02, 2012
PharmTech Talk
36
5
Industry, the public sector, and individuals can play an important role in creating solutions.
Regulation and Compliance: 483 Responses
May 02, 2012
In the Field
36
5
Q&A with David Elder of Strategic Compliance Consulting, PAREXEL International on responding to a 483 within 15 days. Elder is a former senior official with FDA.